Achmea Investment Management B.V. Gilead Sciences, Inc. Transaction History

Achmea Investment Management B.V.

$6.06 Billion
Q3 2024

A detailed history of Achmea Investment Management B.V. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Achmea Investment Management B.V. holds 245,344 shares of GILD stock, worth $22.9 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

245,344

Previous 385,611 36.38%

Holding current value

$22.9 Million

Previous $26.5 Million 22.25%

% of portfolio

0.34%

Previous 0.47%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $9.34 Million - $11.8 Million	-140,267 Reduced 36.38%	245,344 $20.6 Million
Q2 2024 Aug 08, 2024	BUY	$63.15 - $72.88 $4.51 Million - $5.2 Million	71,380 Added 22.72%	385,611 $26.5 Million
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $1.39 Million - $1.69 Million	-19,364 Reduced 5.8%	314,231 $23 Million
Q4 2023 Feb 12, 2024	SELL	$73.27 - $83.09 $5.49 Million - $6.23 Million	-74,953 Reduced 18.35%	333,595 $27 Million
Q3 2023 Nov 06, 2023	BUY	$73.94 - $80.67 $3.63 Million - $3.96 Million	49,096 Added 13.66%	408,548 $30.6 Million
Q2 2023 Jul 24, 2023	BUY	$76.01 - $86.7 $5.46 Million - $6.23 Million	71,866 Added 24.99%	359,452 $27.7 Million
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $8.03 Million - $9.15 Million	103,842 Added 56.51%	287,586 $23.9 Million
Q4 2022 Feb 09, 2023	BUY	$62.32 - $89.47 $859,268 - $1.23 Million	13,788 Added 8.11%	183,744 $14.8 Million
Q3 2022 Oct 27, 2022	SELL	$59.54 - $68.01 $498,826 - $569,787	-8,378 Reduced 4.7%	169,956 $10.5 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $1.58 Million - $1.78 Million	27,399 Added 18.15%	178,334 $11 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $173,586 - $217,522	2,997 Added 2.03%	150,935 $8.97 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $500,289 - $567,838	7,711 Added 5.5%	147,938 $10.7 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $1.53 Million - $1.65 Million	-22,620 Reduced 13.89%	140,227 $9.79 Million
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $1.55 Million - $1.69 Million	-24,420 Reduced 13.04%	162,847 $11.2 Million
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $905,940 - $1.03 Million	15,099 Added 8.77%	187,267 $12.1 Million
Q4 2020 Feb 22, 2021	SELL	$56.65 - $64.55 $223,824 - $255,037	-3,951 Reduced 2.24%	172,168 $10 Million
Q3 2020 Nov 02, 2020	BUY	$62.1 - $78.08 $10.9 Million - $13.8 Million	176,119 New	176,119 $11.1 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $13.2 Million - $16.9 Million	-211,287 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $1.62 Million - $1.78 Million	-26,322 Reduced 11.08%	211,287 $13.7 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $312,299 - $344,724	4,996 Added 2.15%	237,609 $15.1 Million
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $475,285 - $532,977	-7,682 Reduced 3.2%	232,613 $15.7 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.78 Million - $1.99 Million	28,449 Added 13.43%	240,295 $15.6 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $1.15 Million - $1.49 Million	18,916 Added 9.8%	211,846 $13.3 Million
Q3 2018 Nov 06, 2018	SELL	$71.28 - $78.92 $4.01 Million - $4.45 Million	-56,327 Reduced 22.6%	192,930 $14.9 Million
Q2 2018 Jul 27, 2018	SELL	$64.88 - $75.68 $252,642 - $294,697	-3,894 Reduced 1.54%	249,257 $17.7 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $10,124 - $12,343	-139 Reduced 0.05%	253,151 $19.1 Million
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $8.31 Million - $9.75 Million	116,735 Added 85.49%	253,290 $18.1 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $1.07 Million - $1.27 Million	14,884 Added 12.23%	136,555 $11.1 Million
Q2 2017 Aug 29, 2017	BUY	N/A	121,671	121,671 $8.61 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.

Account

Achmea Investment Management B.V. Gilead Sciences, Inc. Transaction History